As anyone should have expected. The recent announcements did not indicate that instant profitability would result.
There is still a great deal of investment required to leverage and maximise the opportunities. While profitability is probably much closer and much more certain - it is still a prospect not a reality.
"Don't be afraid to take a big step if one is indicated. You can't cross a chasm in two small jumps." David Lloyd George
As anyone should have expected. The recent announcements did not indicate that instant profitability would result.
There is still a great deal of investment required to leverage and maximise the opportunities. While profitability is probably much closer and much more certain - it is still a prospect not a reality.
Add to that there is no competition coming thru and even if there was it would be years away.pacific have first mover advantage and plenty of time on their side
Price per test between $NZD1100 and $NZD3400. Marginal cost of test. $NZD100. Nice margin! Current tests 16,000 per annum. Existing lab capacity = 295,000 tests. KP and LCD will open a lot of doors. Future looks good to me.
“Instead of thinking “I’m right”, ask yourself “How do I know I am right?” Find the smartest people to disagree with you so you can stress test your ideas.” Ray Dalio
If you wanted to make a quick buck (not looking at Sharesies investors) then the picture painted is not good.
On the other hand, the long term forecast looks good and the management is highly focused and not trying to take on more than they can handle. A singular focus on the USA makes sense. The medical profession is slow to change. That means a long lead time for sales but once you hook a customer they are unlikely to switch.
....The recent announcements did not indicate that instant profitability would result. ... While profitability is probably much closer and much more certain - it is still a prospect not a reality.
Relax Pierre, I was just trying to explain why the SP has dipped after today's meeting.
Relax Pierre, I was just trying to explain why the SP has dipped after today's meeting.
Still a long term hold in my portfolio.
And a longterm hold in mine too.
Interesting to hear the two sides to covid-19.
Whilst it has, unsurprisingly, increased the uptake of home based testing it's also made it harder for sales staff to go out and sell (hadn't thought of that one).
But with the 2 recent big name customers signing on that minor negative shouldn't be too much of an issue.
Bookmarks